Affiliation:
1. Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
Abstract
The atherogenic impact and functional capacity of LCAT was studied and discussed over a half century. This review aims to clarify the key points that may affect the final decision on whether LCAT is an anti-atherogenic or atherogenic factor. There are three main processes involving the efflux of free cholesterol from peripheral cells, LCAT action in intravascular pool where cholesterol esterification rate is under the control of HDL, LDL and VLDL subpopulations, and finally the destination of newly produced cholesteryl esters either to the catabolism in liver or to a futile cycle with apoB lipoproteins. The functionality of LCAT substantially depends on its mass together with the composition of the phospholipid bilayer as well as the saturation and the length of fatty acyls and other effectors about which we know yet nothing. Over the years, LCAT puzzle has been significantly supplemented but yet not so satisfactory as to enable how to manipulate LCAT in order to prevent cardiometabolic events. It reminds the butterfly effect when only a moderate change in the process of transformation free cholesterol to cholesteryl esters may cause a crucial turn in the intended target. On the other hand, two biomarkers – FERHDL (fractional esterification rate in HDL) and AIP [log(TG/HDL-C)] can offer a benefit to identify the risk of cardiovascular disease (CVD). They both reflect the rate of cholesterol esterification by LCAT and the composition of lipoprotein subpopulations that controls this rate. In clinical practice, AIP can be calculated from the routine lipid profile with help of AIP calculator www.biomed.cas.cz/fgu/aip/calculator.php.
Publisher
Institute of Physiology of the Czech Academy of Sciences
Subject
General Medicine,Physiology
Reference102 articles.
1. ACTON S, RIGOTTI A, LANDSCHULZ KT, XU S, HOBBS HH, KRIEGER M: Identification of scavenger receptor SR-BI as a high-density lipoprotein receptor. Science 271: 518-520, 1996.
2. AIP CALCULATOR is available on www.biomed.cas.cz/fgu/aip/calculator.php
3. AKBAS EM, TIMUROGLU A, OZCICEK A, OZCICEK F, DEMIRTAS L, GUNGOR A, AKBAS N: Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus. Int J Clin Exp Med 7: 5737-5743, 2014.
4. ALBERS JJ, CHEN CH, ADOLPHSON J: Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate. J Lipid Res 22: 1206-1213, 1981.
5. AUSTIN MA, BRESLOW JL, HENNEKENS CH, BURING JE, WILLETT WC, KRAUSS RM: Low-density lipoprotein subclass patterns and the risk of myocardial infarction. JAMA 260: 1917-1921, 1988.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献